Table 4.
Multivariate analysis for clinical outcomes according to the presence of obesity in COVID-19 hospitalized patients.
| Variable | Un-adjusted Model |
Adjusted Model∗ |
||
|---|---|---|---|---|
| OR (95%CI) | p | OR (95%CI) | p | |
| Mortality | ||||
| Normal weight | – | – | – | – |
| Overweight | 0.84 (0.54–1.30) | 0.43 | 1.18 (0.66–2.10) | 0.58 |
| Obesity | 0.87 (0.56–1.34) | 0.52 | 1.53 (0.83–2.79) | 0.17 |
| Morbid obesity | 1.20 (0.65–2.21) | 0.56 | 3.54 (1.46–8.55) | 0.005 |
| Acute kidney injury | ||||
| Normal weight | – | – | – | – |
| Overweight | 1.26 (0.72–2.21) | 0.42 | 1.27 (0.65–2.47) | 0.49 |
| Obesity | 1.44 (0.83–2.49) | 0.19 | 1.85 (0.93–3.67) | 0.08 |
| Morbid obesity | 1.61 (0.77–3.39) | 0.20 | 2.70 (1.01–7.26) | 0.05 |
| Renal replacement therapy | ||||
| Normal weight | – | – | – | – |
| Overweight | 3.08 (0.37–25) | 0.30 | 2.18 (0.25–19.2) | 0.48 |
| Obesity | 7.81 (1.03–59) | 0.05 | 6.31 (0.78–51.1) | 0.08 |
| Morbid obesity | 12 (1.41–102) | 0.02 | 14.4 (1.46–142) | 0.02 |
| Respiratory failure | ||||
| Normal weight | – | – | – | – |
| Overweight | 0.89 (0.57–1.39) | 0.61 | 0.87 (0.49–1.55) | 0.65 |
| Obesity | 0.97 (0.62–1.51) | 0.89 | 1.33 (0.73–2.41) | 0.35 |
| Morbid obesity | 1.54 (0.78–3.04) | 0.21 | 2.91 (1.14–7.48) | 0.03 |
∗ Adjusted by: age, sex, presence of hypertension, qSOFA, hospital stay length, serum hemoglobin, lymphocytes, and ferritin.